COVID-19 has created a lot of volatility in the stock market. Here's why three Motley Fool contributors, in this roundtable discussion, think you might want to discover NRx Pharmaceuticals (NASDAQ: NRXP), FIGS (NYSE: FIGS), and OptimizeRx (NASDAQ: OPRX). George Budwell (NRx Pharmaceuticals): Although NRx Pharmaceuticals has gotten a fair amount of ink from several media outlets in recent months, the biotech's investing thesis has yet to resonate with the broader investing community.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting